Brief: Cantargia Presents Preclinical Data Demonstrating Unique Treatment Effects Of Nadunolimab On Pancreatic Cancer Stromal Cells

Cantargia AB

14/09/2022 04:30

Sept 13 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA PRESENTS PRECLINICAL DATA DEMONSTRATING UNIQUE
TREATMENT EFFECTS OF NADUNOLIMAB ON PANCREATIC CANCER STROMAL
CELLS

Source text for Eikon:  ID:nPreV3mkMa 
Further company coverage:  CANTA.ST 

 ((Reuters.Briefs@thomsonreuters.com;))